Investigation of the cytotoxic and antimicrobial properties of new quinoline peptide conjugates
Author:
Adıyaman Emine1ORCID, Katrancıoğlu Özgür2ORCID, Apohan Elif1ORCID, Küçükbay Hasan1ORCID
Affiliation:
1. INONU UNIVERSITY 2. MALATYA TURGUT OZAL UNIVERSITY, SCHOOL OF MEDICINE
Abstract
Background: Cancer is one of the most important health problems causing deaths in Turkey and the world. Nowadays, many treatment methods such as radiotherapy and chemotherapy are applied in cancer patients. Quinoline and its derivatives, which belong to heterocyclic compounds, have many biological activities for drug development. Quinoline compounds play a crucial role in the development of antitumor drugs due to their anticancer activity.
Materials and Methods: In this study, the cytotoxic effects of synthesized seven different quinoline derivatives on lung cancer (A549) and healthy lung epithelial cell (BEAS2B), liver cancer (Hep 3B), and endothelial cell (HUVEC) were determined. Different concentrations were applied and IC50 values were calculated at different time courses. The antimicrobial activites of the compounds were also determined.
Results: The IC50 values of compound 2 on the A549 cell line were determined to be 10.48 μg/mL, 9.738 μg/mL, and 10.14 μg/mL. IC50 values of compound 6 on the same cell line were determined to be 7.307 µg/mL, 9.888 µg/mL, 10.63 µg/mL.
Conclusions: Compounds 2 and 6 had a cytotoxic effect on the BEAS2B cell line. The antimicrobial activity of the compounds was determined by the minimum inhibition concentration method on different strains of bacteria and yeast. The compounds showed no antimicrobial activity on bacteria and yeast.
Funder
İnönü Üniversitesi
Publisher
Malatya Turgut Ozal University
Reference22 articles.
1. Alegaon, S. G., Parchure, P., Araujo, L. D., Salve, P. S., Alagawadi, K. R., Jalalpure, S. S. & Kumbar, V. M. (2017). Quinoline-azetidinone hybrids: Synthesis and in vitro antiproliferation activity against Hep G2 and Hep 3B human cell lines. Bioorganic & Medicinal Chemistry Letters,27(7), 1566-1571. 2. Alonso, C., Fuertes, M., Martín-Encinas, E., Selas, A., Rubiales, G., Tesauro, C. & Palacios, F. (2018). Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity. European Journal of Medicinal Chemistry, 149, 225-237. 3. Altuner, D., Ekşi, S., Süleyman, H. & Turumtay, E. A. (2021). The effect of usnea longissima extract on lung cancer cell line (A549). ABC Research, 3(1), 1-5. 4. Apohan, E., Yilmaz, U., Yilmaz, O., Serindag, A., Küçükbay, H., Yesilada, O. & Baran, Y. (2017). Synthesis, cytotoxic and antimicrobial activities of novel cobalt and zinc complexes of benzimidazole derivatives. Journal of Organometallic Chemistry,828, 52-58.
Diaconu, D., Mangalagiu, V., Amariucai-Mantu, D., Antoci, V., Giuroiu, C. L. & Mangalagiu, I. I. (2020). 5. Hybridquinoline-sulfonamidecomplexes(M2+) derivativeswithantimicrobialactivity, Molecules, 25(12), 2946.
Dorababu, A. (2020). Report on recently (2017–20) designed quinoline‐based human cancer cell growth inhibitors. ChemistrySelect, 5(44), 13902-13915.
Ferlin, M. G., Chiarelotto, G., Gasparotto, V., Dalla Via, L., Pezzi, V., Barzon, L., Palù, G. & Castagliuolo, I. (2005). Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones. Journal of medicinal chemistry,48(9), 3417-3427.
|
|